Long ‐term comparative safety analysis of the risks associated with adding or switching to a sulfonylurea as second‐line Type 2 diabetes mellitus treatment in a US Veterans Affairs population

Diabetic Medicine,Volume 0, Issue ja, -Not available-.

Source: Diabetic Medicine - October 21, 2018 Category: Endocrinology Authors: W R Powell, C L Christiansen, D R Miller Source Type: research